Uttarakhand authorities revokes ban on 5 Patanjali medicines

On twelfth November 2022, the Uttarakhand authorities revoked the ban imposed on 5 medicines by Patanjali.

Earlier on Wednesday, ninth November 2022, the Uttarakhand Ayurveda and Unani Licensing Authority directed Divya Pharmacy, the maker of Patanjali merchandise, to cease the manufacturing of its 5 medicines viz. BPgrit, Madhugrit, Thyrogrit, Lipidom, and Eyegrit Gold tablets. The ban was imposed after the allegation that these medicines are falsely being promoted for the therapy of blood stress, diabetes, goitre, glaucoma, and excessive ldl cholesterol.

In a letter addressed to the Divya Pharmacy, the licensing officer of Uttarakhand Ayurveda and Unani Services wrote, “Please kindly take the reference of Directorate’s letter dated 09.11.2022 in which the medicines Divya Madhugrit Tablet, Divya Eyegrit Gold, Divya Thyrogrit Tablet, Divya BPgrit Tablet, and Divya Lipidom Tablet being manufactured by your firm are made to stop the manufacturing of. In this regard, as per the provisions mentioned in the Drugs and Cosmetics Act, the firm is given 15 days instead of one week to submit its response.”

Letter by Uttarakhand authorities

The letter additional stated, “Modifying the ban imposed by mistake on the manufacture of the above medicines according to the letter dated 9th November 2022, the permission is granted to keep the production intact.”

Press assertion

Divya Pharmacy revealed a press launch on this challenge after receiving this letter. In this press launch, it says, “Patanjali Institute is the first in the world to get an acceptance for Ayurveda medicines as research and evidence-based medicine with 30 years of continuous effort and research.”

“The Honourable Prime Minister is also making efforts to establish the pride of his heritage by erasing the signs of all kinds of slavery in the country. The ignorant, insensitive, inept Ayurveda licensing officer of Uttarakhand is not only tarnishing the sage tradition of Ayurveda but the injudicious work and errors of an officer have done a grossly condemnable act of questioning the tradition and authentic research of Ayurveda, tarnishing it. And defamed Patanjali maliciously. Such conspiracies are done by people opposed to Yoga-Ayurveda and Indian tradition,” it additional learn.

The assertion additional stated, “It is our duty to make Ayurveda victorious by countering them with scientific research facts and evidence. The department whose job was to establish Ayurveda as the national system of medicine while bringing glory to Ayurveda is engaged in eradicating Ayurveda by defaming Ayurveda. We can never accept this unfortunate act. Patanjali is the first institution in the world to have published the most research papers globally. It has two NABH-accredited hospitals and several NABL-accredited research labs of international standards. More than 500 world-class scientists are providing services here.”

आयुर्वेद को बदनाम करने के इस अविवेकपूर्ण कार्य का संज्ञान लेकर उत्तराखण्ड सरकार ने जिस प्रकार भूल का सुधार किया उसके लिए हम सरकार के प्रति कृतज्ञ हैं कि सरकार द्वारा संज्ञान लेकर इस त्रुटि का सुधार किया गया। pic.twitter.com/1fFffziwMk

— Acharya Balkrishna (@Ach_Balkrishna) November 12, 2022

The press launch added, “In these 75 years of independence, no government or any other institution has done the work done to take Yoga-Ayurveda to the world. We are deeply hurt by the kind of actions committed by an officer. Patanjali will continue its fight against any conspiracy in any way in the establishment of Ayurveda and Yoga or will join any medical mafia or anti-Sanatan conspirators, against him within the scope of the law.”

“We are grateful to the government for the way the Uttarakhand government corrected the mistake by taking cognisance of this imprudent act of defaming Ayurveda and this error was corrected as the government took the cognizance,” stated the press launch, which was additionally shared by Acharya Balkrishna – the managing director of Patanjali Ayurved Limited.

The 5 Patanjali medicines had been banned on ninth November 2022, in response to a criticism filed by Kerala-based ophthalmologist KV Babu in July earlier this yr. Babu despatched one other criticism to the State Licensing Authority (SLA) on October 11 via e-mail. In the in the meantime, Dr. GCN Jangapangi requested in a letter to the joint director of Divya Pharmacy and drug controller of the state well being authority that the pharmacy instantly and going ahead take away “misleading and objectionable ads” from the media area.

Citing deceptive advertisements the regulator additionally directed that Patanjali submit up to date formulation sheets and label claims for every of the 5 formulations for a brand new spherical of product certification. The enterprise may solely resume manufacturing, in response to the ban order of the well being authorities, if the up to date indications have been licensed.